CLINICAL_TRIALS
research
· 2024-10-01
Clinical Trial Update: Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops [Phase 1]
Summary
Clinical trial entry for a Phase 1 study assessing safety and tolerability of NCP112 Eye Drops in xerophthalmia, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Huons Co., Ltd. | Conditions: Xerophthalmia | Phase 1 | Status: RECRUITING